<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><description>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 12 Feb 2021 11:49:25 +0800</pubDate><image><url>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</url><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>回归初心 一同写意</title><link>https://mp.weixin.qq.com/s/WZRLjr8GZWcCC6NPKG4c7g</link><description></description><content:encoded><![CDATA[回归初心 一同写意]]></content:encoded><pubDate>Fri, 12 Feb 2021 11:36:05 +0800</pubDate></item><item><title>FDA批准新型降脂药Evkeeza</title><link>https://mp.weixin.qq.com/s/DHjxer8CSpoieP6M9R1o5w</link><description></description><content:encoded><![CDATA[FDA批准新型降脂药Evkeeza]]></content:encoded><pubDate>Fri, 12 Feb 2021 11:36:05 +0800</pubDate></item><item><title>大年三十，敬您一杯酒</title><link>https://mp.weixin.qq.com/s/xHKDkWMQwuqlLSecTdlQPQ</link><description></description><content:encoded><![CDATA[大年三十，敬您一杯酒]]></content:encoded><pubDate>Thu, 11 Feb 2021 16:02:47 +0800</pubDate></item><item><title>同写意祝大家牛年吉祥，牛气冲天！</title><link>https://mp.weixin.qq.com/s/8wAmyDRg5LUGmpAC_7i-UQ</link><description></description><content:encoded><![CDATA[同写意祝大家牛年吉祥，牛气冲天！]]></content:encoded><pubDate>Thu, 11 Feb 2021 16:02:47 +0800</pubDate></item><item><title>同写意新药临床研发俱乐部理事们来给大家拜年啦！</title><link>https://mp.weixin.qq.com/s/vwjAW-a09BrhUn4htvTAaQ</link><description></description><content:encoded><![CDATA[同写意新药临床研发俱乐部理事们来给大家拜年啦！]]></content:encoded><pubDate>Thu, 11 Feb 2021 16:02:47 +0800</pubDate></item><item><title>写意会员 | 恒诺康创始人张健存博士来给大家拜年啦！</title><link>https://mp.weixin.qq.com/s/NPnPSSdil1Sl1jy7nGUxIw</link><description></description><content:encoded><![CDATA[写意会员 | 恒诺康创始人张健存博士来给大家拜年啦！]]></content:encoded><pubDate>Thu, 11 Feb 2021 16:02:47 +0800</pubDate></item><item><title>写意会员丨亚盛医药董事长杨大俊博士来给大家拜年啦！</title><link>https://mp.weixin.qq.com/s/qZea3YVrgwiCFJkLf7KKGA</link><description></description><content:encoded><![CDATA[写意会员丨亚盛医药董事长杨大俊博士来给大家拜年啦！]]></content:encoded><pubDate>Thu, 11 Feb 2021 16:02:47 +0800</pubDate></item><item><title>写意发布丨Etesevimab（JS016）与bamlanivimab双抗体疗法获FDA紧急使用授权用于治疗COVID-19</title><link>https://mp.weixin.qq.com/s/vyUjWFayo3fFJTrf_JeAIg</link><description></description><content:encoded><![CDATA[写意发布丨Etesevimab（JS016）与bamlanivimab双抗体疗法获FDA紧急使用授权用于治疗COVID-19]]></content:encoded><pubDate>Wed, 10 Feb 2021 20:09:24 +0800</pubDate></item><item><title>关注杜丨礼来与君实的联合抗体疗法获得FDA紧急使用授权</title><link>https://mp.weixin.qq.com/s/CKHqL5EqISqI2j44KtHonw</link><description></description><content:encoded><![CDATA[关注杜丨礼来与君实的联合抗体疗法获得FDA紧急使用授权]]></content:encoded><pubDate>Wed, 10 Feb 2021 20:09:24 +0800</pubDate></item><item><title>巴西Samel医院和科学家对开拓药业普克鲁胺治疗重症新冠患者临床试验表示乐观</title><link>https://mp.weixin.qq.com/s/irBQTxqSIfW3A4VAk8kpIQ</link><description></description><content:encoded><![CDATA[巴西Samel医院和科学家对开拓药业普克鲁胺治疗重症新冠患者临床试验表示乐观]]></content:encoded><pubDate>Wed, 10 Feb 2021 20:09:24 +0800</pubDate></item><item><title>写意会员 | 苏桥生物：基于国际新药开发的技术和质量水平，最快成就客户</title><link>https://mp.weixin.qq.com/s/hh80F3ZVS-c2i-PukIzA5Q</link><description></description><content:encoded><![CDATA[写意会员 | 苏桥生物：基于国际新药开发的技术和质量水平，最快成就客户]]></content:encoded><pubDate>Wed, 10 Feb 2021 20:09:24 +0800</pubDate></item><item><title>写意会员丨未知君联合创始人谭验博士来给大家拜年啦！</title><link>https://mp.weixin.qq.com/s/cYSwZP7ldJaf7yNxrrfGiQ</link><description></description><content:encoded><![CDATA[写意会员丨未知君联合创始人谭验博士来给大家拜年啦！]]></content:encoded><pubDate>Wed, 10 Feb 2021 20:09:24 +0800</pubDate></item><item><title>写意会员丨​博腾董事长居年丰给大家拜年啦！</title><link>https://mp.weixin.qq.com/s/q7heTQCfhkIy-xR_WYZmkg</link><description></description><content:encoded><![CDATA[写意会员丨​博腾董事长居年丰给大家拜年啦！]]></content:encoded><pubDate>Wed, 10 Feb 2021 20:09:24 +0800</pubDate></item><item><title>同写意药学院正式成立，萧柏明任专职院长，钱锋任科学委员会主席</title><link>https://mp.weixin.qq.com/s/FJev-I-uY38xasXtjoneRw</link><description></description><content:encoded><![CDATA[同写意药学院正式成立，萧柏明任专职院长，钱锋任科学委员会主席]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:37:50 +0800</pubDate></item><item><title>NMPA今日发布一大批新药研发指导原则，手机阅读16个guideline</title><link>https://mp.weixin.qq.com/s/BCb7RmPJBn8GHOl76Ti8cw</link><description></description><content:encoded><![CDATA[NMPA今日发布一大批新药研发指导原则，手机阅读16个guideline]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:37:50 +0800</pubDate></item><item><title>写意会员丨开拓药业创始人童友之博士来给大家拜年啦！</title><link>https://mp.weixin.qq.com/s/CDyod-3hfFzG0PhRMB4F-g</link><description></description><content:encoded><![CDATA[写意会员丨开拓药业创始人童友之博士来给大家拜年啦！]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:37:50 +0800</pubDate></item><item><title>写意会员 | 中肽生化创始人李湘博士来给大家拜年啦！</title><link>https://mp.weixin.qq.com/s/mKU0AunSiyeogOGdmeob9w</link><description></description><content:encoded><![CDATA[写意会员 | 中肽生化创始人李湘博士来给大家拜年啦！]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:37:50 +0800</pubDate></item><item><title>福贝生物和Elixiron Immunotherapeutics达成独家授权合作，开发临床阶段CSF1R抑制剂E-1071</title><link>https://mp.weixin.qq.com/s/E0-0TjetcjC9kYPWW3Px-Q</link><description></description><content:encoded><![CDATA[福贝生物和Elixiron Immunotherapeutics达成独家授权合作，开发临床阶段CSF1R抑制剂E-1071]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:37:50 +0800</pubDate></item><item><title>写意会员丨立迪生物董事长闻丹忆博士来给大家拜年啦！</title><link>https://mp.weixin.qq.com/s/6tMUC-G0EX4CsYtuNsdxjw</link><description></description><content:encoded><![CDATA[写意会员丨立迪生物董事长闻丹忆博士来给大家拜年啦！]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:37:50 +0800</pubDate></item><item><title>福贝生物（4B Technologies Ltd）完成A++轮融资，用于推进数个神经系统原创新药进入临床试验</title><link>https://mp.weixin.qq.com/s/kxj-q1qbtAcrYgR1kMdoRA</link><description></description><content:encoded><![CDATA[福贝生物（4B Technologies Ltd）完成A++轮融资，用于推进数个神经系统原创新药进入临床试验]]></content:encoded><pubDate>Tue, 09 Feb 2021 23:37:50 +0800</pubDate></item></channel></rss>